A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from Clostridioides difficile

Area of Science:

• Microbiology
• Molecular Biology
• Biochemistry

Background:

• Clostridioides difficile is a significant pathogen, with enterotoxins A (TcdA) and B (TcdB) being key virulence factors.
• Studying C. difficile toxins is essential for understanding its pathogenicity.
• Current toxin purification methods are inefficient, being either laborious within C. difficile or requiring heterologous expression systems.

Purpose of the Study:

• To develop a streamlined and efficient method for producing and purifying functional TcdA and TcdB directly in C. difficile.
• To facilitate further research into C. difficile virulence mechanisms.

Main Methods:

• Engineered two C. difficile strains (630∆erm) to express His-tagged TcdA and TcdB.
• Utilized the anhydro-tetracycline-inducible Ptet promoter for controlled toxin gene expression.
• Purified recombinant toxins (rTcdA and rTcdB) using standard protein purification techniques.

Main Results:

• Successfully produced and purified biologically active recombinant TcdA (rTcdA) and TcdB (rTcdB) within C. difficile.
• Achieved purification yields of 0.28 mg/L for rTcdA and 0.1 mg/L for rTcdB.
• The purified toxins demonstrated biological activity comparable to native toxins.

Conclusions:

• A simple, routine method for producing and purifying functional C. difficile toxins in their native host has been established.
• This method simplifies the study of C. difficile toxins and their role in virulence.
• The developed technique offers a valuable tool for researchers investigating C. difficile pathogenesis.